Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Christoph Oehler-Jänne"'
Autor:
Van Vuong, Andreas Hollenstein, Michael A. Grotzer, Christoph Oehler-Jänne, André O. von Bueren, Martin Pruschy
Publikováno v:
Biochemical and Biophysical Research Communications. 375:399-404
The phospho-PKB/Akt status is often used as surrogate marker to measure activation of the PI3K/Akt/mTOR signal transduction pathway. Though, inconsistencies of the p-Ser(473)-PKB/Akt status have raised doubts in the validity of p-Ser(473)-PKB/Akt pho
Autor:
Martin Pruschy, Angela Broggini-Tenzer, Christoph Oehler-Jänne, Wolfram Jochum, Van Vuong, Oliver Riesterer
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 6, Iss 1, p 66 (2011)
Radiation Oncology, Vol 6, Iss 1, p 66 (2011)
Background The combined treatment modality of ionizing radiation (IR) with inhibitors of angiogenesis (IoA) is a promising treatment modality based on preclinical in vivo studies using heterotopic xeno- and allograft tumor models. Nevertheless reserv
Autor:
Michael A. Grotzer, Tarek Shalaby, Martin Pruschy, Stefan Rutkowski, AO von Bueren, Christoph Oehler-Jänne
Publikováno v:
Klinische Pädiatrie. 221
Autor:
Michael A. Grotzer, Christoph Oehler-Jänne, Tarek Shalaby, Martin Pruschy, Alexandre Arcaro, Duncan Stearns, Charles G. Eberhart, Lucia Arnold, André O. von Bueren
Publikováno v:
BMC Cancer
BMC cancer, Vol. 9 (2009) P. 10
von Bueren, André O; Shalaby, Tarek; Oehler-Jänne, Christoph; Arnold, Lucia; Stearns, Duncan; Eberhart, Charles G; Arcaro, Alexandre; Pruschy, Martin; Grotzer, Michael A (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio-and chemotherapy in childhood medulloblastoma cells. BMC cancer, 9, p. 10. London: BioMed Central 10.1186/1471-2407-9-10
BMC Cancer, Vol 9, Iss 1, p 10 (2009)
BMC cancer, Vol. 9 (2009) P. 10
von Bueren, André O; Shalaby, Tarek; Oehler-Jänne, Christoph; Arnold, Lucia; Stearns, Duncan; Eberhart, Charles G; Arcaro, Alexandre; Pruschy, Martin; Grotzer, Michael A (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio-and chemotherapy in childhood medulloblastoma cells. BMC cancer, 9, p. 10. London: BioMed Central 10.1186/1471-2407-9-10
BMC Cancer, Vol 9, Iss 1, p 10 (2009)
BackgroundWith current treatment strategies, nearly half of all medulloblastoma (MB) patients die from progressive tumors. Accordingly, the identification of novel therapeutic strategies remains a major goal. Deregulation of c-MYC is evident in numer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6876b3be6926450ad1dd12ea1060409
https://doi.org/10.5167/uzh-28400
https://doi.org/10.5167/uzh-28400
Autor:
Christoph Oehler-Jänne, Margret Ebauer, Beat W. Schäfer, Doriano Fabbro, Torsten Haneke, Marco Wachtel, Ralf Amstutz, Felix Niggli, Heinz Troxler, Peter Kleinert
Inhibition of constitutive active signaling pathways, which are a characteristic phenomenon for many tumors, can be an effective therapeutic strategy. In contrast, oncogenic transcription factors, often activated by mutational events, are in general
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5261e2e5ea9c1908c167b183bebd5d2e
Autor:
Sawyna Provencher, Florence Huguet, I. Frank Ciernik, Abdelkarim S. Allal, Burkhardt Seifert, Marc-Oliver Riener, Christoph Oehler-Jänne, Laura Negretti, Marta Bonet
Publikováno v:
Journal of Clinical Oncology, Vol. 26, No 15 (2008) pp. 2550-7
Purpose To define clinical outcome after definitive chemoradiotherapy (CRT) of anal carcinoma in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Patients and Methods A multicentric cohort comparison of 40 HIV-positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1850976ef7d152b416d7e5dfda045a48
https://archive-ouverte.unige.ch/unige:1781
https://archive-ouverte.unige.ch/unige:1781
Autor:
Ilja F. Ciernik, Laura Negretti, Christian Taverna, Nadine Stanek, Urs M. Lütolf, Christoph Oehler-Jänne
Publikováno v:
Hematological oncology. 26(2)
The role of involved field radiation therapy (IF-RT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for non-Hodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obvia
Autor:
Wolfram Jochum, Giorgio Caravatti, Christoph Oehler-Jänne, Oliver Riesterer, Van Vuong, Angela Broggini-Tenzer, Martin Pruschy
Concomitant inhibition of ErbB1/2- and VEGF receptor-signaling synergizes when used in combination with DNA-damaging agents. Here, we investigated for the first time the combined treatment modality of the novel dual specific receptor tyrosine kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c074d2f1c810b3464dc746304b3cb5a6
https://doi.org/10.5167/uzh-111762
https://doi.org/10.5167/uzh-111762
Autor:
I. Frank Ciernik, Christoph Oehler-Jänne, Burkhardt Seifert, Gabriela Studer, Christoph Glanzmann, Urs M. Lütolf
Purpose To evaluate the outcome after definitive whole pelvis external beam radiotherapy (EBRT) followed by brachytherapy (BT) boost after treatment break vs. external beam boost without break in the treatment of anal carcinoma. Methods and materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804866f6f1f3d445c244debae6e77ad3
https://doi.org/10.5167/uzh-18066
https://doi.org/10.5167/uzh-18066